| Gemini Space Station (GEMI) Facing Securities Class Action Following 75% Post-IPO Collapse – Hagens Berman |
Globe Newswire |
04/06 |
08:57 |
| ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating |
Globe Newswire |
04/06 |
08:57 |
| Coty Inc. (COTY) Facing Securities Class Action Amid Surprise YoY Deterioration in Operating Income, CEO Departure, Withdrawn Guidance -- Hagens Berman |
Globe Newswire |
04/06 |
08:57 |
| HTGC ALERT: Hercules Capital (HTGC) Facing Securities Class Action After Claims Company Copied Google Ventures, Questions Marks and PIKs -- Hagens Berman |
Globe Newswire |
04/06 |
08:54 |
| Trip.com Group (TCOM) Shares Crater Amid Questions Over AI Price Adjustment Tool, Anti-Monopoly Regulatory Probe; Securities Class Action Pending -- Hagens Berman |
Globe Newswire |
04/06 |
08:50 |
| Driven Brands (DRVN) Facing Securities Class Action Alleging Pervasive Accounting Errors and Internal Control Failures Spanning 2023–2025 – Hagens Berman |
Globe Newswire |
04/06 |
08:49 |
| ODDITY Tech. (ODD) Shares Crater 49% Amid “Dislocation” Issue and Expected 30% Decline in Revenue; Securities Class Action Filed -- Hagens Berman |
Globe Newswire |
04/06 |
08:46 |
| CalPrivate Bank Strengthens Leadership Team With Appointment of Michael Pierron as Chief Operating Officer |
Globe Newswire |
04/06 |
08:45 |
| Akari Therapeutics Announces Strategic Partnership with WuXi XDC to Advance Development of Its Novel ADC Payload Targeting RNA Splicing |
Globe Newswire |
04/06 |
08:45 |
| APO INVESTOR ALERT: Hagens Berman Alerts Apollo Global Management (APO) Investors to Securities Class Action Stemming From “Epstein Files” Revelations |
Globe Newswire |
04/06 |
08:41 |
| Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman |
Globe Newswire |
04/06 |
08:40 |
| Diamondback Energy, Inc. Announces Launch of Tender Offers for Any and All of its Outstanding 4.400% Senior Notes due 2051 and 4.250% Senior Notes due 2052 |
Globe Newswire |
04/06 |
08:35 |
| Pacific Office Automation Acquires Western Business Products, Expanding Coverage Across Northern California and Southern Oregon |
Globe Newswire |
04/06 |
08:34 |
| Eos Energy Enterprises (EOSE) Faces Securities Class Action Amid Analyst Questions Over Management’s Transparency, Shares Crater 39% -- Hagens Berman |
Globe Newswire |
04/06 |
08:33 |
| CORT SHAREHOLDER ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss |
Globe Newswire |
04/06 |
08:32 |
| NAVN INVESTOR ALERT: Securities Class Action Alleges Navan’s (NAVN) IPO Materials Omitted to Surge in Sales & Marketing Expenses – Hagens Berman |
Globe Newswire |
04/06 |
08:32 |
| Lakeland Fire + Safety to Host Fiscal Fourth Quarter and Full Year 2026 Financial Results Conference Call on Thursday, April 16, 2026 at 4:30 p.m. Eastern Time |
Globe Newswire |
04/06 |
08:31 |
| A. Duie Pyle Wins American Trucking Association’s President’s Trophy |
Globe Newswire |
04/06 |
08:30 |
| QURE 1-WEEK DEADLINE ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of “Distorted” Data |
Globe Newswire |
04/06 |
08:23 |
| KD 1-WEEK DEADLINE ALERT: Kyndryl (KD) Facing Securities Class Action Amid 55% Stock Drop After Four Bombshell Disclosures – Hagens Berman |
Globe Newswire |
04/06 |
08:16 |
| ORIC Pharmaceuticals, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses |
Globe Newswire |
04/06 |
08:06 |
| Scienture Provides Annual Shareholder Update, Outlining Significant Progress and Strategic Priorities for the Year Ahead |
Globe Newswire |
04/06 |
08:05 |
| Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences |
Globe Newswire |
04/06 |
08:00 |
| Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV262, a Fully CNS-Penetrant NLRP3 Inhibitor |
Globe Newswire |
04/06 |
08:00 |
| KIPRUN OFFICIALLY LAUNCHES IN THE U.S. MARKET |
Globe Newswire |
04/06 |
08:00 |
